Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Madrigal Pharmaceuticals Inc (MDGL)
NASDAQ:MDGL
RESEARCH TOOLSreports
Madrigal Pharmaceuticals (MDGL) Stock Forecast & Price Target
1,037 Followers
See the Price Targets and Ratings of:
MDGL Analyst Ratings
Moderate Buy
10 Buy
2 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MDGL Stock 12 Month Forecast
Average Price Target
$355.33
▲(26.93% Upside)
| Highest Price Target$507.00 | Average Price Target$355.33 | Lowest Price Target$150.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Analyst Performance
Any
Analyst Rating
Any
Upside / Downside
Any
Action
Any
JMP Securities
Reiterated
07/16/24
Cantor Fitzgerald
Initiated
06/28/24
Oppenheimer
Reiterated
06/10/24
TD Cowen
Reiterated
06/10/24
Wolfe Research
Assigned
06/10/24
Citi
Reiterated
06/05/24
Piper Sandler
Reiterated
05/29/24
B.Riley Financial
Reiterated
05/09/24
H.C. Wainwright
Reiterated
05/08/24
Goldman Sachs
Reiterated
05/08/24
Leerink Partners
$390
Buy
39.31%
Upside
Reiterated
05/07/24
Buy Rating Affirmed for Madrigal Pharmaceuticals Amid Strong Start for Rezdiffra
Canaccord Genuity
$377
Buy
34.67%
Upside
Reiterated
05/07/24
Madrigal Pharmaceuticals: Strong Buy Rating Amidst Rapid Growth and Strategic Initiatives
Bank of America Securities
$150
Sell
-46.42%
Downside
Reiterated
05/07/24
Analysts' Opinions Are Mixed on These Healthcare Stocks: Inozyme Pharma (NASDAQ: INZY), Esperion (NASDAQ: ESPR) and Madrigal Pharmaceuticals (NASDAQ: MDGL)
Evercore ISI
$325→$405
Buy
44.67%
Upside
Reiterated
03/19/24
Madrigal Pharmaceuticals (MDGL) PT Raised to $405 at Evercore ISI, well positioned to execute on the launch of RezdiffraEvercore ISI analyst Liisa Bayko raised the price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) to $405.00 (from $325.00) while maintaining a Outperform rating.
UBS
$337→$410
Buy
46.45%
Upside
Reiterated
03/15/24
Madrigal Pharmaceuticals price target raised to $410 from $337 at UBSMadrigal Pharmaceuticals price target raised to $410 from $337 at UBS
Best Analysts Covering Madrigal Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy MDGL and Sell After:
1 Month
xxx
Success Rate
14/24 ratings generated profit
Average Return
+7.35%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 58.33% of your transactions generating a profit, with an average return of +7.35% per trade.
3 Months
xxx
Success Rate
10/15 ratings generated profit
Average Return
+10.07%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +10.07% per trade.
1 Year
Success Rate
13/19 ratings generated profit
Average Return
+19.84%
reiterated a buy rating last month
Copying Ritu Baral's trades and holding each position for 1 Year would result in 68.42% of your transactions generating a profit, with an average return of +19.84% per trade.
2 Years
xxx
Success Rate
14/14 ratings generated profit
Average Return
+130.19%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +130.19% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MDGL Analyst Recommendation Trends
Rating
Feb 24
Mar 24
Apr 24
May 24
Jun 24
Strong Buy
10
16
16
20
16
Buy
10
20
17
11
3
Hold
0
1
1
2
2
Sell
1
2
3
3
2
Strong Sell
0
0
0
0
0
total
21
39
37
36
23
Each month's total comprises the sum of three months' worth of ratings.
MDGL Financial Forecast
MDGL Stock Forecast FAQ
What is MDGL’s average 12-month price target, according to analysts?
Based on analyst ratings, Madrigal Pharmaceuticals Inc’s 12-month average price target is $355.33.
What is MDGL’s upside potential, based on the analysts’ average price target?
Madrigal Pharmaceuticals Inc has 26.93% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MDGL a Buy, Sell or Hold?
Madrigal Pharmaceuticals Inc has a consensus rating of Moderate Buy which is based on 10 buy ratings, 2 hold ratings and 1 sell ratings.
What is Madrigal Pharmaceuticals Inc’s price target?
The average price target for Madrigal Pharmaceuticals Inc is $355.33. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $507.00 ,the lowest forecast is $150.00. The average price target represents 26.93% Increase from the current price of $279.95.
The highest analyst price target is $507.00 ,the lowest forecast is $150.00. The average price target represents 26.93% Increase from the current price of $279.95.
What do analysts say about Madrigal Pharmaceuticals Inc?
Madrigal Pharmaceuticals Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of MDGL?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.